The US drugmaker Moderna has given good news about the Coronavirus vaccine. The company has said that it is going to seek permission for the emergency use of its vaccine in the US and Europe soon. It was claimed a few days ago that this vaccine is up to 94% effective on corona patients. The company said it would soon seek approval from the US Food and Drug Administration.
Vaccination can start from December 21
Moderna CEO Stephen Bansal said the vaccine would be put into the market by December 21 if the process went smoothly and was approved. Moderna has revealed its data announced on Monday in its application. In which the vaccine has been claimed to be effective. The company has claimed that all the necessary scientific criteria have been met during the trial.
Modern’s Corona vaccine will be expensive
Like Pfizer, Moderna’s vaccine has to be stored at a very low temperature. It is a vaccine based on mRNA technology and has been found to be effective up to 94.5%. Moderna has stated the price of her vaccine to be $ 32 to 37 per dose. On large orders, this price may go down further. Nevertheless, it would be very difficult for middle and low-income countries to get this vaccine available.
Moderna’s stock witnessed rapid growth
Moderna’s claim of the vaccine coming into effect has seen a sharp rise in its stock. Moderna shares had gained about 7% due to this news. Buyers are also seeing excitement about the company’s stock.